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Abstract
Background: We examined the utility of serum levels of soluble triggering receptor expressed on myeloid cells-1
(sTREM-1) for the diagnoses, severity assessments, and predicting the prognoses of patients with sepsis and
compared sTREM-1 values with those of C-reactive protein (CRP) and procalcitonin (PCT).
Methods: Fifty-two patients with sepsis were included: 15 sepsis cases and 37 severe sepsis cases (severe sepsis +
septic shock). Serum levels of sTREM-1, CRP, and PCT were determined on days 1, 3, 5, 7, 10, and 14 after
admission to an ICU.
Results: Serum sTREM-1 levels of patients with severe sepsis were significantly higher than for those with sepsis on
day 1 (240.6 pg/ml vs. 118.3 pg/ml; P < 0.01), but CRP and PCT levels were not significantly different between the
two groups. The area under an ROC curve for sTREM-1 for severe sepsis patients was 0.823 (95% confidence
interval: 0.690-0.957). Using 222.5 pg/ml of sTREM-1 as the cut-off value, the sensitivity was 59.5%, the specificity
was 93.3%, the positive predictive value was 95.6%, the negative predictive value was 48.3%, the positive likelihood
ratio was 8.92, and the negative likelihood ratio was 0.434. Based on 28-day survivals, sTREM-1 levels in the
surviving group showed a tendency to decrease over time, while they tended to gradually increase in the non-
surviving group. sTREM-1 levels in the non-surviving group were higher than those in the surviving group at all
time points, whereas CRP and PCT levels showed a tendency to decrease over time in both groups. sTREM-1 levels
and Sequential Organ Failure Assessment (SOFA) scores were positively correlated (r = 0.443; P < 0.001), and this
correlation coefficient was greater than the correlation coefficients for both CRP and PCT.
Conclusions: Serum sTREM-1 levels reflected the severity of sepsis more accurately than those of CRP and PCT and
were more sensitive for dynamic evaluations of sepsis prognosis.
Trial Registration: Current controlled trials ChiCTR-OCH-09000745
Background
Sepsis is the most important cause of morbidity and
m o r t a l i t yi nt h ei n t e n s i v ec a r eu n i t ;h o w e v e r ,s e p s i s
lacks specific clinical manifestations. Thus, it is highly
desirable to find sensitive and specific indicators of
infection that can be easily collected, that accurately
reflect infection severity and prognosis and are clinically
important. Current common clinical indicators of infec-
tion include pyrexia, white blood cell counts, C-reactive
protein (CRP) and procalcitonin (PCT).
Triggering receptor expressed on myeloid cells-1
(TREM-1), discovered by Bouchon et al. in 2000 [1], is a
member of the immunoglobulin superfamily of receptors
that is specifically expressed on the surfaces of mono-
cytes and neutrophils. TREM-1 expression is increased
in infectious diseases and is associated with the release
o fs o l u b l eT R E M - 1( s T R E M - 1 ) .O n es t u d yb yG i b o t
et al. [2] demonstrated that the value of plasma sTREM-
* Correspondence: xielx@263.net
1Department of Respiratory Medicine, Chinese PLA General Hospital, 28
Fuxing Road, Beijing, China
Full list of author information is available at the end of the article
Zhang et al. BMC Infectious Diseases 2011, 11:53
http://www.biomedcentral.com/1471-2334/11/53
© 2011 Zhang et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.1 levels as an indicator of sepsis was superior to CRP
and PCT, although other studies reported that the value
of sTREM-1 for diagnosing sepsis was inferior to CRP
and PCT [3-5].
The purpose of this study was to track changes in
serum sTREM-1, CRP and PCT levels in patients with
sepsis and to compare the predictive values of these
three factors for assessing sepsis and establishing
prognosis.
Methods
Subjects
Between September 2009 and March 2010, inpatients
were included who were in the intensive care units
(ICU) of the Department of Respiratory Disease, the
Emergency Department, and the Department of Surgery
of the Chinese People’s Liberation Army General Hospi-
tal. These patients were diagnosed with sepsis, severe
sepsis, or septic shock according to the 1991 ACCP/
SCCM Joint Meeting [6] and by the diagnostic criteria
developed at the 2001 International Sepsis Definition
Conference [7]. Patients were excluded if they were < 18
years old, died within 24 hours of admission, had neu-
tropenia (< 500 neutrophils/mm
3), had an acquired
immunodeficiency syndrome, or refused to participate
in this study.
Patients were divided into a sepsis group and a severe
sepsis group (severe sepsis + septic shock), and additional
analysis was based on 28-day survivals for a surviving
group (≥ 28 days survival) and those who died (< 28 days
survival). Patients or their family members were fully
informed and signed informed consent forms. This study
was approved by the Ethics Committee of the Chinese
PLA General Hospital (project number 20090923-001).
Data collection
Demographic and disease data of patients included age,
gender, chief complaint for admission, vital signs, rou-
tine blood test results, liver and kidney functions, coagu-
lation indicators, Acute Physiologic Assessment and
Chronic Health Evaluation (APACHE) II scores, and
Sequential Organ Failure Assessment (SOFA) scores.
These were recorded on days 1, 3, 5, 7, 10, and 14.
Serum was collected at these same time points and
sTREM-1, CRP and PCT levels were determined.
Assays
sTREM-1 was determined using a double antibody sand-
wich ELISA (Quantikine Human TREM-1 Immunoassay
ELISA Kit, R & D Systems, Minneapolis, MN, USA, pro-
duct number DTRM10B). CRP was determined using
scattering turbidimetry (CardioPhase hsCRP, Siemens,
Germany) and PCT was measured using an enzyme-
linked fluorescence analysis kit (ELFA, VIDAS BRAHMS
PCT kit, bioMerieux SA, France). All assays were
performed according to the manufacturer’s instructions.
Statistical analysis
Quantitative data with normal distributions, including
age, APACHE II scores, body temperature, and white
blood cell counts (WBC), are given as means ± standard
deviations (SD). Student’s t-test was used to compare
means between two groups. Quantitative data that were
not normally distributed, including sTREM-1, CRP, PCT
and SOFA scores, were summarized as medians (inter-
quartile ranges) and compared by non-parametric tests
(Mann-Whitney U test). Proportions were used to
express qualitative data and the differences in propor-
tions between groups were compared using a chi-square
test. Spearman correlation coefficients were used to
assess associations between SOFA scores and sTREM-1,
CRP and PCT levels. Statistical analysis used SPSS
Statistics 17.0.
Results
Patient Characteristics
Fifty-two patients with sepsis were included in this
study. There were 15 cases with sepsis and 37 cases
with severe sepsis. Thirty-one patients were male
(59.6%) and the mean patient age was 56 ± 19 years.
Initial sites of infection were the lungs (50%), blood
(23%), and abdomen (13%). Patients’ ages and day 1
temperatures were not significantly different between
the two groups (P >0 . 0 5 ) .H o w e v e r ,t h eA P A C H EI I
scores and white blood cell counts in the severe sepsis
group were higher than those of the sepsis group (P =
0.006 and P = 0.003, respectively).
Comparisons of initial sTREM-1, CRP and PCT levels
Serum sTREM-1 levels of patients in the severe sepsis
group were significantly higher than those in the sepsis
group on day 1 (240.6 pg/ml vs. 118.3 pg/ml, P < 0.01),
but there were no significant differences in CRP or PCT
levels between the two groups. SOFA scores of the
severe sepsis group were significantly higher than those
of the sepsis group (6 vs. 3; P < 0.001; Table 1).
ROC curves for APACHE II scores, WBCs, SOFA
scores and sTREM-1 levels for the two groups were
Table 1 Serum sTREM-1, CRP, PCT levels and SOFA scores
on day of enrollment
Parameter Sepsis
(n = 15)
Severe sepsis
(n = 37)
P value
sTREM-1 (pg/ml) 118.3 (124.5) 240.6 (180.2) < 0.001
CRP (mg/dl) 10.60 (11.50) 11.70 (12.95) 0.920
PCT (ng/ml) 0.21 (2.50) 1.31 (15.03) 0.132
SOFA score 3 (4) 6 (6) < 0.001
*: Data are presented as median (interquartile range).
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(Figure 1) for calculating the areas under the ROC
curves (Table 2). These results showed that combining
both sTREM-1 and SOFA scores was better than any
single indicator for diagnosing severe sepsis. We used
the maximum Youden Index (YI) to select cut-off cri-
teria values. Using a cut-off value for sTREM-1 of 222.5
pg/ml, the sensitivity was 59.5%, the specificity was
93.3%, the positive predictive value was 95.6%, the nega-
tive predictive value was 48.3%, the positive likelihood
ratio was 8.92 and the negative likelihood ratio was
0.434 for severe sepsis diagnosis. Using a cut-off value
for SOFA scores of 3.5, the sensitivity was 78.4% and
the specificity was 66.7% for severe sepsis diagnosis.
Dynamic changes of sTREM-1, CRP and PCT levels
To assess dynamic changes in serum levels of serum
sTREM-1, CRP and PCT levels, patients were divided
into either a surviving group (≥ 28 days survival) or a
non-surviving group (< 28 days survival) based on 28-
day survivals (Table 3). The number of patients in the
non-surviving group decreased with increasing mortality.
Thus, the actual numbers of patients in the non-surviv-
ing group were 16, 16, 14, 14, 12, and 9 on days 1, 3, 5,
7, 10, and 14, respectively. For patients who died within
14 days of admission, the last measurements obtained
before these patients died were used for each of the
time points after a patient’s death.
Median serum sTREM-1, CRP and PCT levels deter-
mined on days 1, 3, 5, 7, 10, and 14, and were compared
between the surviving and non-surviving groups
(Figure 2). Serum sTREM-1, CRP and PCT levels in the
non-surviving group tended to be higher than those in
the surviving group. In particular, serum sTREM-1, CRP
and PCT levels in the non-surviving group were higher
than those in the surviving group on days 1, 3, 5, and 7,
although the differences were not statistically significant
between the two groups (P > 0.05). Serum sTREM-1,
CRP and PCT levels in the non-surviving group were,
however, significantly higher than those in the surviving
group on days 10 and 14 (P < 0.05).
Longitudinally, serum sTREM-1, CRP and PCT levels
in the surviving group showed a tendency to decrease
over time (P < 0.001). In the non-surviving group, the
sTREM-1 levels tended to gradually increase with time,
but the changes in sTREM-1 levels were not statistically
significant (P = 0.222). In contrast, CRP and PCT levels
tended to decrease over time, especially within the first
3 days.
Patients with higher seruml e v e l so fs T R E M - 1 ,C R P
and PCT had poorer prognoses. Compared with the ten-
dency for changing levels of CRP and PCT, the gradual
increase of sTREM-1 levels was a better reflection of the
progression of sepsis, which was of greater value for
predicting death.
Figure 1 ROC curves for APACHE II scores, WBCs, SOFA scores
and sTREM-1 levels for distinguishing severe sepsis from
sepsis.
Table 2 Area under ROC curve on diagnosing severe
sepsis
Parameters AUC Standard
error (SE)
P value 95% confidence
interval
Lower
limit
Upper
limit
sTREM-1 0.823 0.068 0.000 0.690 0.957
SOFA 0.823 0.060 0.000 0.706 0.939
sTREM-1+ SOFA 0.886 0.047 0.000 0.795 0.978
APACHE II score 0.726 0.078 0.011 0.574 0.879
WBC 0.735 0.074 0.008 0.590 0.880
Table 3 Comparison of patient demographics and clinical
data between the survival group (≥ 28 days) and the
non-survival group (< 28 days) based on 28-day survival
Clinical features Survival group
(n = 36)
Non-survival group
(n = 16)
P-value
Age (years) 59 ± 18 51 ± 22 NS
Male/Female 22/14 9/7 NS
Initial WBC (10^9/L) 12.4 ± 5.9 14.1 ± 5.9 NS
Initial APACHE II score 14.9 ± 7.1 19.7 ± 7.3 0.03
Initial SOFA score 4.0 (4.75) 9.5 (5.75) 0.001
sTREM-1 (pg/ml) 193.4 (179.9) 240.2 (257.5) NS
CRP (mg/dl) 10.85 (11.48) 11.95 (12.20) NS
PCT (ng/ml) 0.68 (10.93) 1.33 (12.26) NS
*: Data are presented as mean ± standard deviation, number, or median
(interquartile range).
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PCT levels
SOFA scores in the surviving group were lower than those
in the non-surviving group on day 1 (4.0 vs. 9.5; Z =
-3.387; P = 0.001). SOFA scores in the surviving group
gradually decreased as the course of the disease pro-
gressed. There was no apparent decrease in SOFA scores
for the non-surviving group. Rather, SOFA scores in the
non-surviving group showed a tendency to increase during
the last days (Figure 3), suggesting that SOFA scores were
closely related to the severity and prognosis of sepsis.
As shown in Figure 4 Spearman correlation analysis
was used evaluate the associations between SOFA scores
and serum sTREM-1, CRP and PCT (logarithmic values
of PCT were used for this analysis). The correlation
coefficients (r) were 0.443, 0.257, and 0.406, respectively
(P < 0.001).
Discussion
During the course of sepsis, TREM-1 amplifies infec-
tion-induced inflammatory response signals primarily
through the mediation of adapter protein DAP12 on the
cell surface. sTREM-1 is the soluble form of TREM-1
that lacks the transmembrane and intracellular domains.
These two domains are cleaved from TREM-1 on the
membrane surface by proteolysis [8]. In 2009, a meta-
analysis [9] found that the sensitivity of sTREM-1 for
diagnosing bacterial infection was 0.82 (95% confidence
interval [CI]: 0.68-0.90) and the specificity was 0.86
(95% CI: 0.77-0.91). These high values suggested that
sTREM-1 was a reasonably reliable indicator for diag-
nosing bacterial infections.
Compared with previous studies, our study found that
sTREM-1 was a valuable tool for diagnosing severe sepsis
(severe sepsis + septic shock) with organ dysfunction.
sTREM-1 levels in the severe sepsis group were signifi-
cantly higher than those in the sepsis group starting at
day 1 of ICU admission. Thus, sTREM-1 measurements
may be useful for an early diagnosis of severe sepsis and
timely intervention. There were no significant differences
for either CRP or PCT levels between the sepsis and
severe sepsis groups, implying that serum sTREM-1 was
superior to CRP and PCT for diagnosing severe sepsis.
In our study, the sensitivity and specificity of sTREM-
1 for diagnosing severe sepsis were 59.5% and 93.3%,
respectively. The low sensitivity value may have been
related to the small sample size, and follow-up studies
should include larger samples. SOFA scores had a
Figure 2 Serum levels of (A) sTREM-1, (B) CRP, and (C) PCT
measured over 14 days in patients diagnosed with sepsis
based on 28-day survival.
Figure 3 Comparison of SOFA scores between patients in the
surviving and non-surviving groups.
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fore, combining both sTREM-1 levels and SOFA scores
may be more valuable for diagnosing severe sepsis com-
pared with any single indicator.
In our study, patients with more severe conditions had
higher SOFA scores. Additionally, SOFA scores in the
non-surviving group tended to increase over time, while
they decreased gradually in the surviving group. Thus,
SOFA scores can dynamically reflect an improvement in
ap a t i e n t ’s condition, or even the progression of sepsis.
Consistent with the results of Dimopoulou et al. [10], we
also found that serum sTREM-1 levels were positively
correlated with the SOFA scores. Compared with CRP
and PCT, sTREM-1 had a higher correlation with SOFA
scores, suggesting that sTREM-1 was more closely
related to disease conditions than both CRP and PCT.
During the 14-day observation period, sTREM-1 levels
in the non-surviving group increased gradually over
time, whereas sTREM-1 levels tended to gradually
decrease in the surviving group. This indicates that the
inflammatory indicator sTREM-1 may be associated
with sepsis prognosis. That is, a progressively decreasing
expression of sTREM-1 indicates that the infection-
induced inflammatory responses are being controlled
and that a patient’s prognosis is good.
sTREM-1 is primarily produced by the hydrolysis and
shedding of membrane-bound TREM-1. Thus, progres-
sive increases of sTREM-1 levels indicate that the total
expression of TREM-1 continuously increases and that
more pro-inflammatory cytokines and mediators are
being released in the body. TREM-1 levels are further
increased via positive feedback mechanisms, suggesting
the persistence or progression of excessive inflammatory
responses and poor prognoses.
Different from sTREM-1 levels, CRP and PCT levels
i nt h es u r v i v i n gg r o u pw e r el o w e rt h a nt h o s ei nt h e
non-surviving group, indicating that patients with higher
expressions of CRP and PCT may have poorer prog-
noses (although CRP and PCT levels tended to decrease
in both groups over time). Overall, these results suggest
that dynamic changes of sTREM-1 may better reflect
the body’s state of inflammatory response and sepsis
severity simultaneously making sTREM-1 superior to
CRP and PCT. Progressive increases in serum sTREM-1
levels is an indicator of a poor prognosis.
The changing trends for sTREM-1, CRP and PCT
identified in the current study were consistent with
those in previous studies [11,12]. Nonetheless, it remains
debatable whether or not initial sTREM-1 levels are
directly related to prognosis. Gibot et al. [11] found that
initial sTREM-1 levels in a non-surviving group were
Figure 4 Correlation between SOFA scores and serum (A)
sTREM-1, (B) CRP, and (C) PCT levels. The Spearman correlation
coefficients (r) were 0.443, 0.257, and 0.406 (P < 0.001) between
SOFA and serum sTREM-1, CRP, and PCT respectively (the
logarithmic value of PCT was used for analysis).
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that prognosis would be poorer for patients with lower
initial sTREM-1 levels. One possible reason for this
finding is a hypothesis that sTREM-1 may compete with
membrane-bound TREM-1 for ligand binding and
thereby attenuate the transmission of infectious signals
from membrane-bound TREM-1 into cells. Thus, the
release of pro-inflammatory cytokines and mediators
may be reduced and excessive inflammatory reactions
and injury may be abrogated. Another possible reason is
that inhibitory DAP12 receptors are present on the cell
membrane that can bind with sTREM-1. DAP12 recep-
tors negatively regulate TLR signalling pathways, thereby
preventing excessive inflammatory responses. Thus,
sTREM-1 may have certain anti-inflammatory and pro-
tective effects [13]. Patients with low levels of sTREM-1
are prone to excessive inflammatory responses and have
poor prognoses.
Our results are consistent with those reported by Gia-
marellos-Bourboulis et al. [12] who reported that initial
sTREM-1 levels in a non-surviving group were higher
than those in a surviving group. There are several possi-
ble reasons for this observation. First, sTREM-1 is pro-
duced when membrane-bound TREM-1 is cleaved from
the cell surface. High expression levels of sTREM-1
reflect the high expression of membrane-bound TREM-
1. The initial disease conditions were more severe in the
non-surviving group and systemic inflammatory reac-
tions were obvious. The expression of membrane-bound
TREM-1 increased and the inflammatory reaction
caused injury to the body’s cells and tissues resulting in
the production of endogenous inflammatory pathogenic
factors and an increase in the expression of TREM-1.
As a result, the initial sTREM-1 levels in the non-surviv-
ing group were higher than those in the surviving group.
Second, although sTREM-1 may have some anti-inflam-
matory effects, infections were not well controlled in the
non-surviving group. As a result, inflammatory
responses overwhelmed the body’s compensatory anti-
inflammatory capacities. This excessive inflammatory
response was persistent resulting in a continuous high
expression of membrane-bound TREM-1 and an
increase in the total amount of sTREM-1 produced by
its hydrolysis. Third, because some of our patients
developed sepsis at other hospitals and were transferred
to the ICU due to poor therapeutic effects, the observed
initial sTREM-1 levels might not actually have been the
levels at the onset of sepsis. Instead, the measured levels
might actually have been at a later stage in the non-sur-
viving group, which were higher than those measured in
the surviving group. Finally, the small sample size for
this study could also have influenced the results.
Although the relationship between initial sTREM-1 levels
and prognosis remains controversial, multiple studies had
similar findings showing that patients with progressively
decreasing sTREM-1 levels had better prognoses, whereas
patients with progressively increasing sTREM-1 levels had
poorer prognoses.
Conclusions
In summary, sTREM-1 levels can reflect sepsis severity
more accurately than CRP and PCT and the dynamic
changes of sTREM-1 are more sensitive for predicting
prognosis. However, the sample size for this study was
quite small and larger studies are needed.
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